An improved method for growing and analysing human antigen-specific CD4 + T-cell clones

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 8, 2011, Pages 906-912

  Ciantar, Joseph P ^a   Mannering, Stuart I ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Autoimmune disease; CFSE; Proinsulin; T cell cloning; Type 1 diabetes

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; INTERLEUKIN 4; THYMIDINE;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL CLONING; CELL GROWTH; CELL ISOLATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL SEPARATION; CLONE CELLS; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; INTERLEUKINS; PROINSULIN;

EID: 80855131150     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1271     Document Type: Article

References (21)

1. Mannering SI, Wong FS, Durinovic-Bello I, et al. Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes. Clin Exp Immunol 2010; 162(2): 197-209.
2. Martinuzzi E, Novelli G, Scotto M, et al. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes 2008; 57(5): 1312-1320.
3. Durinovic-Bello I, Rosinger S, Olson JA, et al. DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype. Proc Natl Acad Sci U S A 2006; 103(31): 11683-11688.
4. Altman JD, Moss PA, Goulder PJ, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274(5284): 94-96.
5. Oling V, Marttila J, Ilonen J, et al. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J Autoimmun 2005; 25(3): 235-243.
6. Dunbar PR, Chen JL, Chao D, et al. Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. J Immunol 1999; 162(12): 6959-6962.
7. Nepom GT, Buckner JH, Novak EJ, et al. HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells. Arthritis Rheum 2002; 46(1): 5-12.
8. Manz R, Assenmacher M, Pfluger E, Miltenyi S, Radbruch A. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc Natl Acad Sci U S A 1995; 92(6): 1921-1925.
9. Mannering SI, Morris JS, Jensen KP, et al. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J Immunol Methods 2003; 283(1-2): 173-183.
10. Mannering SI, Morris JS, Stone NL, Jensen KP, Vane PM, Harrison LC. CD4+ T cell proliferation in response to GAD and proinsulin in healthy, pre-diabetic, and diabetic donors. Ann N Y Acad Sci 2004; 1037: 16-21.
11. Mannering SI, Dromey JA, Morris JS, Thearle DJ, Jensen KP, Harrison LC. An efficient method for cloning human autoantigen-specific T cells. J Immunol Methods 2005; 298(1-2): 83-92.
12. Mannering SI, Harrison LC, Williamson NA, et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 2005; 202(9): 1191-1197.
13. Mannering SI, Pang SH, Williamson NA, et al. The A-chain of insulin is a hot-spot for CD4+ T cell epitopes in human type 1 diabetes. Clin Exp Immunol 2009; 156(2): 226-231.
14. Riddell SR, Greenberg PD. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods 1990; 128(2): 189-201.
15. Campbell PD, Estella E, Dudek NL, et al. Cytotoxic T-lymphocyte-mediated killing of human pancreatic islet cells in vitro. Hum Immunol 2008; 69(9): 543-551.
16. Mannering SI, McKenzie JL, Fearnley DB, Hart DN. HLA-DR1-restricted bcr-abl (b3a2)-specific CD4+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates. Blood 1997; 90(1): 290-297.
17. Mannering SI, Purcell AW, Honeyman MC, McCluskey J, Harrison LC. Human T-cells recognise N-terminally Fmoc-modified peptide. Vaccine 2003; 21(25-26): 3638-3646.
18. De Plaen E, Lurquin C, Lethe B, et al. Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes. Methods 1997; 12(2): 125-142.
19. Gueguen M, Patard JJ, Gaugler B, et al. An antigen recognized by autologous CTLs on a human bladder carcinoma. J Immunol 1998; 160(12): 6188-6194.
20. Cowley DJ, Mackin RB. Expression, purification and characterization of recombinant human proinsulin. FEBS Lett 1997; 402(2-3): 124-130.
21. Moon HC, Joffe M, Thomas HE, Kay TWH, Mannering SI. A method for extracting tissue proteins for use in lymphocyte function assays. J Immunol Methods 2010; 359(1-2): 56-60.